Cargando…
Procalcitonin as a Biomarker for Malignant Cerebral Edema in Massive Cerebral Infarction
The objective of this study is to explore whether procalcitonin (PCT) can serve as an early biomarker of malignant cerebral edema in patients with massive cerebral infarction (MCI). Ninety-three patients with acute MCI were divided into death or survival groups based on whether they died or survived...
Autores principales: | Zhang, Yan, Liu, Gang, Wang, Yuan, Su, Yingying, Leak, Rehana K., Cao, Guodong |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5772664/ https://www.ncbi.nlm.nih.gov/pubmed/29343753 http://dx.doi.org/10.1038/s41598-018-19267-4 |
Ejemplares similares
-
Butyphthalide in the treatment of massive Cerebral Infarction
por: Wang, Xinmin, et al.
Publicado: (2019) -
20-hydroxyeiscosatetraenoic acid may be as a predictor of malignant middle cerebral artery infarction in patients with massive middle cerebral artery infarction
por: Yi, Xingyang, et al.
Publicado: (2021) -
Medical management of cerebral edema in large hemispheric infarcts
por: DeHoff, Grace, et al.
Publicado: (2022) -
Predictive Value of Degranulating Factors of Neutrophils in Massive
Cerebral Infarction
por: Huang, Yuyou, et al.
Publicado: (2021) -
Microglia-mediated neuroinflammation and neuroplasticity after stroke
por: Wang, Yuan, et al.
Publicado: (2022)